Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ANX > SEC Filings for ANX > Form 8-K on 26-Oct-2012All Recent SEC Filings

Show all filings for ADVENTRX PHARMACEUTICALS INC

Form 8-K for ADVENTRX PHARMACEUTICALS INC


26-Oct-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On October 25, 2012, ADVENTRX Pharmaceuticals, Inc. issued a press release announcing details of its planned phase 3 clinical study of ANX-188 (purified poloxamer 188) in sickle cell disease. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The list of exhibits called for by this Item is incorporated by reference to the Exhibit Index filed with this report.


Top of the Form

  Add ANX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ANX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.